The global Bovine Mastitis Market is estimated to be valued at US$ 1497.52 Mn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Bovine mastitis refers to the inflammation of mammary glands and udder of dairy cows. It is caused due to bacterial infection and it reduces milk production as well as milk quality. Timely diagnosis and appropriate treatment helps in reducing the severity and recurrence rate of mastitis.

Market key trends:
One of the key market trends is the increasing research and development activities focused on development of better detection methods and new treatment options for bovine mastitis. Manufacturers are investing in development of rapid diagnostic tests and vaccines for major mastitis causing pathogens. These initiatives will help in early detection and prevention of mastitis, thereby supporting growth of this market.

Market Key Trends:
The Bovine Mastitis Market is witnessing increasing adoption of advanced diagnostic tools for timely diagnosis of mastitis in dairy cattle. Various players are focusing on development and commercialization of rapid on-site tests as well as automated milk screening technologies for improved mastitis detection. For instance, companies are providing portable optical scanning devices that can screen milk samples for presence of bacteria and cell count abnormalities indicative of mastitis. Such advanced testing solutions are helping farmers and veterinarians to detect subclinical mastitis at an early stage and commence appropriate treatment.

SWOT Analysis
Strength: Availability of various treatment options such as antibiotics, bacteriophages, vaccines etc. allows customized therapy based on causative agent and infection stage.
Weakness: High livestock management cost and extensive labor needs for monitoring animal health on dairy farms.
Opportunity: Rising livestock agriculture in developing nations presents potential for market expansion.
Threats: Issues regarding antibiotic residue in milk and need for prudent antimicrobial usage. Growing preference for alternative therapies over antibiotics.

Key Takeaways
The global bovine mastitis market size was valued at US$ 1497.52 Mn in 2023 and is expected to reach US$ 2536.67 Mn by 2030, expanding at a CAGR of 5.2%.
The North America region dominated the market in 2023, accounting for around 35% of global revenue, followed by Europe. High dairy farming intensity and growing adoption of advanced diagnostic technologies are driving market growth in these regions.
Key players operating in the bovine mastitis market are Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.

Read More: http://igniteblog01.weebly.com/blog/the-development-of-combinational-mastitis-treatments-is-anticipated-to-open-up-the-new-avenue-for-bovine-mastitis-market